|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/14/24 Larimar Therapeutics, Inc. 10-K 12/31/23 63:10M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.22M
4: EX-10.20 Material Contract HTML 525K
5: EX-10.21 Material Contract HTML 100K
2: EX-10.3 Material Contract HTML 33K
3: EX-10.4 Material Contract HTML 45K
6: EX-21.1 Subsidiaries List HTML 20K
7: EX-23.1 Consent of Expert or Counsel HTML 19K
11: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 39K
Awarded Compensation
8: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
13: R1 Document and Entity Information HTML 93K
14: R2 Consolidated Balance Sheets HTML 109K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K
16: R4 Consolidated Statements of Operations and HTML 75K
Comprehensive Loss
17: R5 Consolidated Statements of Changes in HTML 65K
Stockholders' Equity
18: R6 Consolidated Statements of Cash Flows HTML 87K
19: R7 Pay vs Performance Disclosure HTML 32K
20: R8 Insider Trading Arrangements HTML 26K
21: R9 Description of Business and Organization HTML 44K
22: R10 Summary of Significant Accounting Policies HTML 49K
23: R11 Fair Value Measurements and Cash HTML 161K
Equivalents/Marketable Securities
24: R12 Prepaid Expenses and Other Current Assets HTML 36K
25: R13 Fixed Assets HTML 50K
26: R14 Accrued Expenses HTML 36K
27: R15 Stockholders? Equity and Stock Options HTML 160K
28: R16 Commitments and Contingencies HTML 63K
29: R17 Income Taxes HTML 122K
30: R18 Summary of Significant Accounting Policies HTML 102K
(Policies)
31: R19 Fair Value Measurements and Cash HTML 151K
Equivalents/Marketable Securities (Tables)
32: R20 Prepaid Expenses and Other Current Assets (Tables) HTML 36K
33: R21 Fixed Assets (Tables) HTML 47K
34: R22 Accrued Expenses (Tables) HTML 35K
35: R23 Stockholders? Equity and Stock Options (Tables) HTML 127K
36: R24 Commitments and Contingencies (Tables) HTML 36K
37: R25 Income Taxes (Tables) HTML 111K
38: R26 Description of Business and Organization - HTML 48K
Additional Information (Detail)
39: R27 Summary of Significant Accounting Policies - HTML 45K
Additional Information (Detail)
40: R28 Fair Value Measurements and Cash HTML 27K
Equivalents/Marketable Securities - Additional
Information (Detail)
41: R29 Fair Value Measurements and Cash HTML 47K
Equivalents/Marketable Securities - Summary of
Cash Equivalents and Marketable Securities
(Detail)
42: R30 Fair Value Measurements and Cash HTML 41K
Equivalents/Marketable Securities - Summary of
Marketable Securities (Detail)
43: R31 Prepaid Expenses and Other Current Assets - HTML 28K
Schedule of Prepaid Expenses and Other Current
Assets (Detail)
44: R32 Fixed Assets - Schedule of Fixed Assets, Net HTML 38K
(Detail)
45: R33 Fixed Assets - Additional Information (Detail) HTML 23K
46: R34 Accrued Expenses - Schedule of Accrued Expenses HTML 28K
(Detail)
47: R35 Stockholders Equity and Stock Options - Additional HTML 173K
Information (Detail)
48: R36 Stockholders Equity and Stock Options - HTML 29K
Assumptions used to Determine Fair Value of Stock
Options Granted (Detail)
49: R37 Stockholders Equity and Stock Options - Summary of HTML 65K
Stock Option Activity (Detail)
50: R38 Stockholders Equity and Stock Options - Summary of HTML 49K
Restricted Stock Units (Details)
51: R39 Stockholders Equity and Stock Options - Summary of HTML 34K
Stock-Based Compensation Expense (Detail)
52: R40 Commitments and Contingencies - Additional HTML 127K
Information (Detail)
53: R41 Commitments and Contingencies - Schedule of HTML 38K
Maturities of Lease Liabilities Due Under Lease
Agreements (Detail)
54: R42 Income Taxes - Additional Information (Detail) HTML 69K
55: R43 Income Taxes - Schedule of Domestic and Foreign HTML 29K
Components of Loss Before Income Taxes (Detail)
56: R44 Income Taxes - Reconciliation of Federal Statutory HTML 39K
Income Tax Rate (Detail)
57: R45 Income Taxes - Schedule of Net Deferred Tax Assets HTML 51K
(Detail)
58: R46 Income Taxes - Summary of Changes in the Valuation HTML 24K
Allowance for Deferred Tax Assets (Detail)
60: XML IDEA XML File -- Filing Summary XML 111K
63: XML XBRL Instance -- lrmr-20231231_htm XML 1.60M
59: EXCEL IDEA Workbook of Financial Report Info XLSX 122K
12: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 2.64M
Linkbases Document -- lrmr-20231231
61: JSON XBRL Instance as JSON Data -- MetaLinks 457± 705K
62: ZIP XBRL Zipped Folder -- 0000950170-24-031529-xbrl Zip 1.36M
| EX-97.1 |
LARIMAR THERAPEUTICS, INC.
COMPENSATION RECOVERY POLICY
Adopted as of September 21, 2023
Larimar Therapeutics, Inc., a Delaware corporation (the “Company”), has adopted this Compensation Recovery Policy (this “Policy”) as described below.
1. Overview
This Policy sets forth the circumstances and procedures under which the Company shall recover Erroneously Awarded Compensation from Covered Persons (as defined below) in accordance with rules issued by the United States Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Exchange. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section 3 below.
2. Compensation Recovery Requirement
In the event the Company is required to prepare a Financial Restatement, the Company shall recover reasonably promptly all Erroneously Awarded Compensation with respect to such Financial Restatement.
3. Definitions
2
4. Exception to Compensation Recovery Requirement
The Company may elect not to recover Erroneously Awarded Compensation pursuant to this Policy if the Committee determines that recovery would be impracticable, and one or more of the following conditions, together with any further requirements set forth in the Applicable Rules, are met: (i) the direct expense paid to a third party, including outside legal counsel, to assist in enforcing this Policy would exceed the amount to be recovered, and the Company has made a reasonable attempt to recover such Erroneously Awarded Compensation; or (ii) recovery would likely cause an otherwise tax-qualified retirement plan to fail to be so qualified under applicable regulations.
7. Tax Considerations
To the extent that, pursuant to this Policy, the Company is entitled to recover any Erroneously Awarded Compensation that is received by a Covered Person, the gross amount received (i.e., the amount the Covered Person received, or was entitled to receive, before any deductions for tax withholding or other payments) shall be returned by the Covered Person.
8. Method of Compensation Recovery
3
The Committee shall determine, in its sole discretion, the method for recovering Erroneously Awarded Compensation hereunder, which may include, without limitation, any one or more of the following:
Notwithstanding the foregoing, a Covered Person will be deemed to have satisfied such person’s obligation to return Erroneously Awarded Compensation to the Company if such Erroneously Awarded Compensation is returned in the exact same form in which it was received; provided that equity withheld to satisfy tax obligations will be deemed to have been received in cash in an amount equal to the tax withholding payment made.
9. Policy Interpretation
This Policy shall be interpreted in a manner that is consistent with the Applicable Rules and any other applicable law. The Committee shall take into consideration any applicable interpretations and guidance of the SEC in interpreting this Policy, including, for example, in determining whether a financial restatement qualifies as a Financial Restatement hereunder. To the extent the Applicable Rules require recovery of Incentive-Based Compensation in additional circumstances besides those specified above, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Incentive-Based Compensation to the fullest extent required by the Applicable Rules.
10. Policy Administration
This Policy shall be administered by the Committee. The Committee shall have such powers and authorities related to the administration of this Policy as are consistent with the governing documents of the Company and applicable law. The Committee shall have full power and authority to take, or direct the taking of, all actions and to make all determinations required or provided for under this Policy and shall have full power and authority to take, or direct the taking of, all such other actions and make all such other determinations not inconsistent with the specific terms and
4
provisions of this Policy that the Committee deems to be necessary or appropriate to the administration of this Policy. The interpretation and construction by the Committee of any provision of this Policy and all determinations made by the Committee under this policy shall be final, binding and conclusive.
11. Compensation Recovery Repayments not Subject to Indemnification
Notwithstanding anything to the contrary set forth in any agreement with, or the organizational documents of, the Company or any of its subsidiaries, Covered Persons are not entitled to indemnification for Erroneously Awarded Compensation or for any claim or losses arising out of or in any way related to Erroneously Awarded Compensation recovered under this Policy.
5
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/14/24 | 8-K | ||
| For Period end: | 12/31/23 | |||
| 10/2/23 | ||||
| 9/21/23 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/14/24 Larimar Therapeutics, Inc. S-8 3/14/24 4:75K Donnelley … Solutions/FA 3/14/24 Larimar Therapeutics, Inc. S-8 3/14/24 4:79K Donnelley … Solutions/FA |